Reinhold Kreutz Selected Research

finerenone

5/2021	Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease.
1/2021	Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension.
1/2020	Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Frömter Rats, a Genetic Model of Chronic Kidney Disease.
1/2018	Finerenone Attenuates Endothelial Dysfunction and Albuminuria in a Chronic Kidney Disease Model by a Reduction in Oxidative Stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reinhold Kreutz Research Topics

Disease

51	Hypertension (High Blood Pressure) 05/2022 - 08/2001
19	Albuminuria 05/2021 - 07/2002
15	Venous Thromboembolism 03/2021 - 01/2012
14	Hemorrhage 03/2021 - 01/2012
12	Chronic Renal Insufficiency 05/2021 - 06/2015
11	Cardiovascular Diseases (Cardiovascular Disease) 05/2021 - 12/2006
10	Pain (Aches) 01/2022 - 08/2015
9	Drug-Related Side Effects and Adverse Reactions 01/2022 - 03/2011
9	Stroke (Strokes) 12/2021 - 07/2004
9	Atrial Fibrillation 12/2021 - 11/2012
8	Venous Thrombosis (Deep-Vein Thrombosis) 04/2019 - 11/2012
8	Fibrosis (Cirrhosis) 04/2011 - 10/2002
7	Hypertrophy 08/2011 - 07/2002
6	Heart Failure 12/2021 - 07/2006
6	Agranulocytosis (Granulocytopenia) 10/2020 - 03/2014
6	Proteinuria 01/2019 - 12/2003
5	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2022 - 07/2002
5	Diabetes Mellitus 12/2021 - 10/2006
4	Chronic Pain 01/2022 - 02/2016
4	Renal Insufficiency (Renal Failure) 05/2021 - 10/2003
4	Diabetic Nephropathies (Diabetic Nephropathy) 05/2021 - 07/2006
4	COVID-19 01/2021 - 01/2020
4	Thrombosis (Thrombus) 10/2020 - 06/2017
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2011
4	Neoplasms (Cancer) 07/2017 - 01/2016
4	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2016 - 01/2007
4	Body Weight (Weight, Body) 02/2012 - 02/2003
3	Disease Progression 05/2021 - 01/2011
3	Genetic Predisposition to Disease (Genetic Predisposition) 10/2020 - 09/2004
3	Pulmonary Embolism 01/2020 - 01/2016
3	Obesity 01/2020 - 01/2011
3	Kidney Diseases (Kidney Disease) 01/2019 - 10/2018
3	Cardiomyopathies (Cardiomyopathy) 01/2016 - 01/2012
2	Erectile Dysfunction 01/2022 - 01/2020
2	Cardiomegaly (Heart Hypertrophy) 01/2022 - 07/2003
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2021
2	Inflammation (Inflammations) 01/2022 - 01/2019
2	Neutropenia 10/2020 - 01/2020
2	Myocarditis (Carditis) 01/2020 - 08/2014
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2019 - 01/2006
2	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 01/2018
2	Thrombocytopenia (Thrombopenia) 01/2018 - 10/2017

Drug/Important Bio-Agent (IBA)

18	RivaroxabanIBA 03/2021 - 01/2012
14	SaltsIBA 05/2022 - 08/2001
12	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 10/2002
12	Pharmaceutical PreparationsIBA 01/2019 - 02/2004
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2005
8	Messenger RNA (mRNA)IBA 01/2019 - 10/2002
7	AnticoagulantsIBA 12/2021 - 01/2016
6	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022 - 01/2006
5	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 01/2011
5	Angiotensin Receptor AntagonistsIBA 01/2021 - 10/2014
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 07/2006
5	CreatinineIBA 07/2017 - 01/2007
5	CholesterolIBA 01/2017 - 09/2004
5	olmesartanIBA 01/2015 - 07/2008
5	Endothelins (Endothelin)IBA 01/2007 - 10/2002
4	SodiumIBA 12/2021 - 01/2021
4	finerenoneIBA 05/2021 - 01/2018
4	salicylhydroxamic acid (SHAM)IBA 01/2021 - 09/2009
4	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 08/2005
4	CollagenIBA 04/2016 - 02/2003
4	AlbuminsIBA 11/2007 - 10/2003
4	Angiotensin IIIBA 07/2007 - 07/2002
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2016
3	Dipyrone (Metamizole)IBA 10/2020 - 02/2015
3	LipidsIBA 10/2020 - 09/2004
3	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 10/2019 - 10/2014
3	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 10/2018
3	Enoxaparin (Lovenox)FDA LinkGeneric 10/2018 - 01/2014
3	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 07/2017
3	AutoantibodiesIBA 01/2016 - 01/2012
3	EnzymesIBA 09/2013 - 08/2005
3	OsteopontinIBA 05/2013 - 07/2002
3	Atrial Natriuretic Factor (ANF)IBA 04/2011 - 10/2002
3	Triglycerides (Triacylglycerol)IBA 01/2011 - 01/2007
3	Endothelin A ReceptorIBA 01/2007 - 10/2002
2	Ramipril (Altace)FDA LinkGeneric 01/2022 - 09/2013
2	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2022 - 10/2002
2	PotassiumIBA 01/2022 - 01/2020
2	Vitamin K FDA Link 12/2021 - 04/2019
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021 - 01/2015
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2021 - 10/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 01/2018
2	DiureticsIBA 10/2019 - 01/2006
2	HLA-B Antigens (HLA-B)IBA 01/2018 - 01/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2017
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 03/2014
2	ORALIT (ORS)IBA 04/2016 - 01/2016
2	Tissue Inhibitor of Metalloproteinase-1IBA 04/2016 - 01/2006

Therapy/Procedure

30	Therapeutics 05/2022 - 01/2005
7	Home Nursing (Nursing, Home) 01/2020 - 01/2013
5	Polypharmacy 01/2022 - 01/2013
4	Renal Dialysis (Hemodialysis) 01/2022 - 01/2013
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2013
4	Pain Management 01/2022 - 08/2015
3	Secondary Prevention 10/2020 - 01/2014
2	Ambulatory Care (Outpatient Care) 12/2020 - 12/2019
2	Kidney Transplantation 01/2018 - 12/2002
2	Orthopedic Procedures 03/2016 - 01/2012